‘Shwas Kavach’ Initiative Gains Government Recognition for AI-Enabled Last-Mile Medical Oxygen Network

Date:

Share post:

Shwas Kavach, an initiative aimed at strengthening India’s last-mile medical oxygen supply, has received recognition and support from the Office of the Principal Scientific Adviser (PSA) to the Government of India. The project was formally endorsed on the government’s Manthan platform on 8th May 2026 as an AI-enabled, decentralized model for delivering oxygen to healthcare facilities across the country.

The initiative is being developed by CPDMED at the Indian Institute of Science, Bengaluru, together with Newttorr Pumps and Systems Private Limited. It proposes an AI-linked network covering all 778 districts in India, connecting government and military healthcare facilities down to the primary health centre level, supported by a round-the-clock toll-free helpline linking healthcare facilities and oxygen resources. Central to the plan are containerised, IoT-enabled oxygen cylinder filling units to be set up at district drug warehouses, allowing real-time monitoring of purity, pressure, volume and pricing. Once fully implemented, the network is expected to establish approximately 60,165 cylinder banks across district and taluka hospitals, community and primary health centres, along with military, air force and naval hospitals.

The initiative draws on lessons from the pandemic years, when large-scale investment in oxygen generation infrastructure was not enough for timely access to healthcare, especially in rural areas, as supply chains remained concentrated in urban centres. Many home-based patients are reported to have gone without oxygen in time, with such cases often left undocumented.

Shwas Kavach is positioned as a preparedness framework for future health emergencies, built to keep medical oxygen consistently available, accessible, affordable and accountable, down to the village level. Newttorr has also piloted what it describes as India’s first IoT-enabled oxygen cylinder filling station under its Oxy Aid brand.

Special thanks to Mr. Mallikarjun Dandinawar for his valuable support and contribution. 

Written By: Sayan Das

Graphics by: Pramit Hazra

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related articles

India’s First AYUSH University to Build 100-Acre Permanent Campus in Kurukshetra, Haryana

The Ministry of Ayush announced the development of the permanent campus for India’s first dedicated AYUSH University, sprawling across nearly...

Pfizer-BioNTech’s Updated COVID-19 Vaccine Gets FDA Nod for 2026-2027

Pfizer Inc. and BioNTech SE said Thursday that U.S. regulators have cleared their refreshed COVID-19 shot, giving American providers a...

Maharashtra FDA Seizes ₹11.19 Lakh Reactin Plus Stock from Cipla Facility

The Maharashtra Food and Drug Administration (FDA) has cancelled the drug sale licence of Cipla Pharma & Life...

Department of Pharmaceuticals Reopens ₹5,000 Crore Pharma Innovation Scheme for Second Round of Applications

India's Department of Pharmaceuticals has opened a fresh application window for its flagship Promotion of Research and Innovation...